Cited by 47Epilepsy research and treatmentTuberous Sclerosis Complex ResearchNeuroscience and Neuropharmacology Research

Architectural (Type IA) Focal Cortical Dysplasia and Parvalbumin Immunostaining in Temporal Lobe Epilepsy

Open access
Garbelli, Rita, Meroni, Alessandra, Magnaghi, Giuseppina, Beolchi, Maria Sana, Ferrario, Arianna, Tassi, Laura, Bramerio, Manuela, Spreafico, Roberto·2006·Epilepsia

Abstract

Summary: Purpose:We analyzed 26 surgically treated patients operated on for intractable epilepsy associated with type IA (architectural) cortical dysplasia, to investigate neuropathologic and immunocytochemical features, particularly of the γ‐aminobutyric acid (GABA)ergic system, and to compare the findings with those observed in normal cortex. Methods:. Routinely stained slides and serial sections immunostained for neurofilaments (SMI 311), microtubule‐associated protein‐2 (MAP‐2), neuron‐specific nuclear protein (NeuN), glial fibrillary acidic protein (GFAP), parvalbumin (PV), calbindin (CB), and calretinin (CR) were processed. Some sections were processed by using single‐immunoperoxidase procedures; others were processed for double immunofluorescence labelling and observed by confocal microscopy. The density of inhibitory PV‐immunoreactive interneurons was quantitatively assessed in all patients and control cases by using a two‐dimensional cell‐counting technique on PV immunostained sections. Results:The density of PV‐immunoreactive interneurons was significantly reduced in this group of patients, whereas CB‐ and CR‐ positivity appeared similar to those in normal cortex. In five cases, architectural abnormalities, in addition to those that defined type 1A dysplasia, were present and characterized by abnormal clusters of neurons and laminar cellular loss in superficial cortical laminate. Conclusions:The reduction of PV expression in type IA cortical dysplasia suggests an impairment of the GABAergic system as a possible mechanism for the epileptogenicity; in addition, PV immunoreactivity can be helpful in the neuropathologic characterization of this form of cortical dysplasia.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1528-1167.2006.00577.x

Cites

15 of 15 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Epilepsy and prion disease are among other disorders associated with alterations in PV-INs.

    “Epilepsy [63,64] and prion disease [65] are among other disorders that are associated with alterations in PV-INs.”

    From Parvalbumin interneuron vulnerability and brain disorders (2021) · cites this paper as [64]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Garbelli, R., Meroni, A., Magnaghi, G., Beolchi, M. S., Ferrario, A., Tassi, L., Bramerio, M., & Spreafico, R.
Affiliations
  • Fondazione IRCCS Istituto Neurologico Carlo Besta (IT)
  • Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda (IT)
Venue
Epilepsia
Publisher
Wiley
Published
2006-06
Volume
47
Issue
6
Pages
1074-1078
ISSN
  • 0013-9580 (ISSN-L)
  • 1528-1167
OpenAlex
W2069899587
Cited by
47
References
15
Citations by year
2026: 1 · 2024: 1 · 2022: 1 · 2021: 2 · 2020: 2 · 2019: 1 · 2017: 2 · 2016: 1 · 2015: 4 · 2014: 2 · 2013: 4 · 2012: 4
FWCI
2.54
Type
journal article
Language
en
Open access
Locations
  • Epilepsia (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Ministero della Salute (RF2003)
  • Ministero dell’Istruzione, dell’Università e della Ricerca (2003068749)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Epilepsy research and treatment
  • Health Sciences › Medicine › Physiology › Tuberous Sclerosis Complex Research
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
Keywords
parvalbumin, temporal lobe epilepsy, GABAergic system, inhibitory interneurons, epileptogenicity, calbindin, calretinin, neuropathology, immunocytochemistry
MeSH terms
Adolescent, Adult, Cell Count, Epilepsy, Temporal Lobe, Fluorescent Antibody Technique, Humans, Immunoenzyme Techniques, Immunohistochemistry, Interneurons, Microtubule-Associated Proteins, Middle Aged, Nerve Tissue Proteins, Parvalbumins, Phenothiazines, Staining and Labeling, Temporal Lobe, Microscopy, Confocal, Antigens, Nuclear, Calbindins, S100 Calcium Binding Protein G, Calbindin 2

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review